Modifiers of heart and muscle function: Where genetics meets physiology

Experimental Physiology

Volumn 99, Issue 4, 2014, Pages 621-626

  Swaggart, Kayleigh A ^a   Mcnally, Elizabeth M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN; DYSTROPHIN ASSOCIATED PROTEIN; GAMMA SARCOGLYCAN; HYDROXYPROLINE; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN 4; UNCLASSIFIED DRUG;

ARTICLE; BECKER MUSCULAR DYSTROPHY; BREATHING MUSCLE; CARDIOPULMONARY FUNCTION; CELL DAMAGE; CELL MEMBRANE; CHROMOSOME 2; CHROMOSOME 7; DISEASE SEVERITY; DUCHENNE MUSCULAR DYSTROPHY; FRAMESHIFT MUTATION; GENETIC VARIABILITY; HAPLOTYPE; HEART FUNCTION; HEART MUSCLE; HEART MUSCLE FIBROSIS; HUMAN; INDEL MUTATION; LIMB GIRDLE MUSCULAR DYSTROPHY; LUNG VASOCONSTRICTION; MEDICAL GENETICS; MUSCLE FIBER MEMBRANE; MUSCLE FUNCTION; MUSCULAR DYSTROPHY; NONHUMAN; OXYGEN SATURATION; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGICAL PROCESS; QUANTITATIVE TRAIT LOCUS; QUANTITATIVE TRAIT LOCUS MAPPING; SARCOLEMMA; SCAR FORMATION; SINGLE NUCLEOTIDE POLYMORPHISM; SKELETAL MUSCLE; ANIMAL; DISEASE MODEL; EXERCISE TOLERANCE; GENETIC PREDISPOSITION; GENETICS; HEART DISEASE; MOUSE; MUSCLE CONTRACTION; MUSCLE DISEASE; PATHOLOGY; PROTECTION; RISK FACTOR;

ANIMALS; DISEASE MODELS, ANIMAL; EXERCISE TOLERANCE; GENETIC PREDISPOSITION TO DISEASE; HEART DISEASES; HUMANS; MICE; MUSCLE CONTRACTION; MUSCLE, SKELETAL; MUSCULAR DISEASES; MYOCARDIUM; PHENOTYPE; PROTECTIVE FACTORS; QUANTITATIVE TRAIT LOCI; RISK FACTORS;

EID: 84897077837     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2013.075887     Document Type: Article

References (16)

1. Birnkrant DJ, Ashwath ML, Noritz GH, Merrill MC, Shah TA, Crowe CA & Bahler RC (2010). Cardiac and pulmonary function variability in Duchenne/Becker muscular dystrophy: an initial report. J Child Neurol 25, 1110-1115.
2. Clark LD, Clark RK & Heber-Katz E (1998). A new murine model for mammalian wound repair and regeneration. Clin Immunol Immunopathol 88, 35-45.
3. Crisp A, Yin H, Goyenvalle A, Betts C, Moulton HM, Seow Y, Babbs A, Merritt T, Saleh AF, Gait MJ, Stuckey DJ, Clarke K, Davies KE & Wood MJ (2011). Diaphragm rescue alone prevents heart dysfunction in dystrophic mice. Hum Mol Genet 20, 413-421.
4. D'Angelo MG, Romei M, Lo Mauro A, Marchi E, Gandossini S, Bonato S, Comi GP, Magri F, Turconi AC, Pedotti A, Bresolin N & Aliverti A (2011). Respiratory pattern in an adult population of dystrophic patients. J Neurol Sci 306, 54-61.
5. Flanigan KM, Ceco E, Lamar KM, Kaminoh Y, Dunn DM, Mendell JR, King WM, Pestronk A, Florence JM, Mathews KD, Finkel RS, Swoboda KJ, Gappmaier E, Howard MT, Day JW, McDonald C, McNally EM & Weiss RB; United Dystroretinopathy Project (2012). LTBP4 genotype predicts age of ambulatory loss in duchenne muscular dystrophy. Ann Neurol 73, 481-488.
6. Ghosh AK, Quaggin SE & Vaughan DE (2013). Molecular basis of organ fibrosis: potential therapeutic approaches. Exp Biol Med (Maywood) 238, 461-481.
7. Heydemann A, Ceco E, Lim JE, Hadhazy M, Ryder P, Moran JL, Beier DR, Palmer AA & McNally EM (2009). Latent TGF-β-binding protein 4 modifies muscular dystrophy in mice. J Clin Invest 119, 3703-3712.
8. Heydemann A, Huber JM, Demonbreun A, Hadhazy M & McNally EM (2005). Genetic background influences muscular dystrophy. Neuromuscul Disord 15, 601-609.
9. Heydemann A, Swaggart KA, Kim GH, Holley-Cuthrell J, Hadhazy M & McNally EM (2012). The superhealing MRL background improves muscular dystrophy. Skelet Muscle 2, 26.
10. Kefi M, Amouri R, Driss A, Ben Hamida C, Ben Hamida M, Kunkel LM & Hentati F (2003). Phenotype and sarcoglycan expression in Tunisian LGMD 2C patients sharing the same del521-T mutation. Neuromuscul Disord 13, 779-787.
11. Kucherenko MM, Pantoja M, Yatsenko AS, Shcherbata HR, Fischer KA, Maksymiv DV, Chernyk YI & Ruohola-Baker H (2008). Genetic modifier screens reveal new components that interact with the Drosophila dystroglycan-dystrophin complex. PLoS One 3, e2418.
12. McBrearty BA, Clark LD, Zhang XM, Blankenhorn EP & Heber-Katz E (1998). Genetic analysis of a mammalian wound-healing trait. Proc Natl Acad Sci U S A 95, 11792-11797.
13. McNally EM, Passos-Bueno MR, Bönnemann CG, Vainzof M, de Sá Moreira E, Lidov HG, Othmane KB, Denton PH, Vance JM, Zatz M & Kunkel LM (1996). Mild and severe muscular dystrophy caused by a single gamma-sarcoglycan mutation. Am J Hum Genet 59, 1040-1047.
14. Romei M, D'Angelo MG, LoMauro A, Gandossini S, Bonato S, Brighina E, Marchi E, Comi GP, Turconi AC, Pedotti A, Bresolin N & Aliverti A (2012). Low abdominal contribution to breathing as daytime predictor of nocturnal desaturation in adolescents and young adults with Duchenne Muscular Dystrophy. Respir Med 106, 276-283.
15. Swaggart KA, Heydemann A, Palmer AA & McNally EM (2011). Distinct genetic regions modify specific muscle groups in muscular dystrophy. Physiol Genomics 43, 24-31.
16. Todorovic V & Rifkin DB (2012). LTBPs, more than just an escort service. J Cell Biochem 113, 410-418.